• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用较不敏感的 HIV 感染率检测方法进行实验室性能的标准化和监测以及质量保证:七年的结果。

Standardization and monitoring of laboratory performance and quality assurance by use of the less-sensitive HIV incidence assay: seven years of results.

机构信息

Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA, USA.

出版信息

J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):482-8. doi: 10.1097/QAI.0b013e318230dd77.

DOI:10.1097/QAI.0b013e318230dd77
PMID:21857352
Abstract

BACKGROUND

The Performance Evaluation Program for HIV-1 incidence tests provided quality assurance services to laboratories conducting the serological testing algorithm for recent HIV seroconversion by use of a modified less-sensitive version of the Vironostika HIV-1 MicroElisa System assay. We report on the performance of the assay using proficiency testing and quality control materials tested from 2001 to 2008.

METHODS

Two sets of 5 blinded serum panels using common calibration and quality control materials were tested. The mean, standard deviation, and coefficient of variation were calculated. Results were analyzed for misclassifications: false recent HIV infection errors (long-term infection classified as HIV infection less than 1 year), false long-term infection errors (HIV infection less than 1 year classified as long-term infection), and differences in standardized optical density means and variances over time.

RESULTS

The false recent error rate was 1.26% (n = 2219). The false long-term error rate was 0.25% (n = 1618). No significant trends were observed for misclassification rates by year, and no significant trend in the standardized optical density over 7 years was observed.

CONCLUSIONS

Laboratories using the less-sensitive Vironostika HIV-1 assay produced consistent results by use of a common calibrator and quality control materials.

摘要

背景

HIV-1 感染发生率检测的性能评估计划为使用 Vironostika HIV-1 MicroElisa 系统检测方法的改良低灵敏度版本进行近期 HIV 血清转化血清学检测的实验室提供了质量保证服务。我们报告了使用能力验证和质量控制材料在 2001 年至 2008 年进行检测的该检测方法的性能。

方法

使用常见的校准和质量控制材料测试了两组 5 份盲血清板。计算平均值、标准差和变异系数。分析结果的错误分类:假近期 HIV 感染错误(长期感染归类为感染少于 1 年),假长期感染错误(少于 1 年的 HIV 感染归类为长期感染),以及标准化光密度均值和方差随时间的差异。

结果

假近期错误率为 1.26%(n = 2219)。假长期错误率为 0.25%(n = 1618)。按年份观察不到错误分类率的显著趋势,并且在 7 年内标准化光密度也没有观察到显著趋势。

结论

使用改良低灵敏度 Vironostika HIV-1 检测方法的实验室通过使用常见的校准品和质量控制材料产生了一致的结果。

相似文献

1
Standardization and monitoring of laboratory performance and quality assurance by use of the less-sensitive HIV incidence assay: seven years of results.利用较不敏感的 HIV 感染率检测方法进行实验室性能的标准化和监测以及质量保证:七年的结果。
J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):482-8. doi: 10.1097/QAI.0b013e318230dd77.
2
Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence.一种用于估计HIV血清发病率的新型低敏感性HIV-1酶免疫测定法的性能特征
J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):625-34. doi: 10.1097/00126334-200308150-00012.
3
Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.利用限制抗原亲和力测定法开发用于 HIV-1 发病率的国际外部质量保证计划。
PLoS One. 2019 Sep 16;14(9):e0222290. doi: 10.1371/journal.pone.0222290. eCollection 2019.
4
Modification of rapid human immunodeficiency virus (HIV) antibody assay protocols for detecting recent HIV seroconversion.用于检测近期人类免疫缺陷病毒(HIV)血清转化的快速HIV抗体检测方案的改进
Clin Diagn Lab Immunol. 2005 Aug;12(8):918-21. doi: 10.1128/CDLI.12.8.918-921.2005.
5
Reconciling HIV incidence results from two assays employed in the serological testing algorithm for recent HIV seroconversion (STARHS).协调近期HIV血清转化血清学检测算法(STARHS)中使用的两种检测方法得出的HIV发病率结果。
J Virol Methods. 2003 Nov;113(2):79-86. doi: 10.1016/s0166-0934(03)00222-2.
6
Improving the safety of the blood supply in Ecuador through external performance evaluation of serological screening of blood donors.通过对献血者血清学筛查进行外部绩效评估来提高厄瓜多尔血液供应的安全性。
J Clin Virol. 2005 Dec;34 Suppl 2:S47-52. doi: 10.1016/s1386-6532(05)80034-4.
7
Comparison of two serological tests for the identification of recent HIV infection: Vironostika HIV-1 Microelisa and BED capture enzyme immunoassay.两种用于识别近期HIV感染的血清学检测方法的比较:Vironostika HIV-1微酶免疫测定法和BED捕获酶免疫测定法。
Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):553-5. doi: 10.1016/j.eimc.2011.02.016. Epub 2011 Apr 17.
8
Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand.使用生物梅里埃Vironostika-LS检测法评估一种敏感/低敏感检测算法,以检测泰国近期的HIV-1 B'或E亚型感染情况。
AIDS Res Hum Retroviruses. 2003 Jun;19(6):481-6. doi: 10.1089/088922203766774522.
9
A comprehensive evaluation of the proficiency testing program for the HIV-1 BED incidence assay.HIV-1 BED 发生率检测试剂室间质量评价方案的综合评估
J Clin Microbiol. 2011 Oct;49(10):3470-3. doi: 10.1128/JCM.01122-11. Epub 2011 Aug 10.
10
Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II.通过纳入HIV p24抗原检测,直接抗HIV-1/-2检测在血清转化中的敏感性得到显著增强:新一代Vironostika HIV Uni-Form II。
J Virol Methods. 1998 Dec;76(1-2):59-71. doi: 10.1016/s0166-0934(98)00126-8.

引用本文的文献

1
Evaluation of the Abbott ARCHITECT HIV Ag/Ab combo assay for determining recent HIV-1 infection.评价 Abbott ARCHITECT HIV Ag/Ab combo assay 检测 HIV-1 近期感染的应用。
PLoS One. 2021 Jul 1;16(7):e0242641. doi: 10.1371/journal.pone.0242641. eCollection 2021.
2
Altered Antibody Responses in Persons Infected with HIV-1 While Using Preexposure Prophylaxis.感染 HIV-1 的个体在使用暴露前预防时抗体反应的改变。
AIDS Res Hum Retroviruses. 2021 Mar;37(3):189-195. doi: 10.1089/AID.2020.0137. Epub 2020 Dec 9.
3
Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.
利用限制抗原亲和力测定法开发用于 HIV-1 发病率的国际外部质量保证计划。
PLoS One. 2019 Sep 16;14(9):e0222290. doi: 10.1371/journal.pone.0222290. eCollection 2019.
4
A Multiplex HIV Incidence Assay for Inferring Recent HIV-1 Transmission and Time of Infection.一种用于推断近期 HIV-1 传播和感染时间的多重 HIV 感染率检测方法。
J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):454-460. doi: 10.1097/QAI.0000000000001937.
5
Performance characteristics of an antibody-based multiplex kit for determining recent HIV-1 infection.一种用于确定近期HIV-1感染的基于抗体的多重检测试剂盒的性能特征
PLoS One. 2017 May 4;12(5):e0176593. doi: 10.1371/journal.pone.0176593. eCollection 2017.
6
Development of a proficiency testing program for the HIV-1 BED incidence assay in China.中国HIV-1 BED发病率检测能力验证计划的制定。
Sci Rep. 2014 Mar 28;4:4512. doi: 10.1038/srep04512.